RAMSEY, N.J. (AP) — RAMSEY, N.J. (AP) — Adma Biologics Inc. (ADMA) on Wednesday reported fourth-quarter earnings of $49.4 million.
On a per-share basis, the Ramsey, New Jersey-based company said it had net income of 20 cents.
The infectious disease drug developer posted revenue of $139.2 million in the period.
For the year, the company reported profit of $146.9 million, or 60 cents per share. Revenue was reported as $510.2 million.
Adma Biologics expects full-year revenue of $635 million.
Adma Biologics shares have dropped 14% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $15.68, a rise of nearly 2% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
